Colgate-Palmolive
1,092 hedge funds and large institutions have $39.6B invested in Colgate-Palmolive in 2013 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 382 increasing their positions, 451 reducing their positions, and 55 closing their positions.
13% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 55
4% more capital invested
Capital invested by funds: $38.3B → $39.6B (+$1.35B)
0.41% more ownership
Funds ownership: 71.6% → 72.01% (+0.41%)
0% less funds holding
Funds holding: 1,095 → 1,092 (-3)
7% less funds holding in top 10
Funds holding in top 10: 43 → 40 (-3)
15% less repeat investments, than reductions
Existing positions increased: 382 | Existing positions reduced: 451
23% less call options, than puts
Call options by funds: $297M | Put options by funds: $385M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$248M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$164M |
| 3 |
HCM
Herndon Capital Management
Atlanta,
Georgia
|
+$85.1M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$78.1M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$59.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$224M |
| 2 |
MAM
Magellan Asset Management
Sydney,
Australia
|
-$146M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$102M |
| 4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$95.4M |
| 5 |
State Street
Boston,
Massachusetts
|
-$63.2M |
CL Hedge Fund Activity: Q3 2013 in Review
1,092 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Colgate-Palmolive (CL) for Q3 2013, worth a combined $39.6B — up 3.5% from $38.3B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new CL positions and 55 closed out — a net gain of 7 holders — while 382 added to existing stakes and 451 trimmed.
The largest buyer was OppenheimerFunds, adding an estimated $248M. The largest seller was T. Rowe Price Associates, cutting an estimated $224M.
- 1,092 institutional investors held Colgate-Palmolive (CL) as of Q3 2013, down from 1,095 in Q2 2013.
- Funds reported $39.6B of Colgate-Palmolive stock for Q3 2013, up 3.5% quarter-over-quarter.
- 62 funds opened new Colgate-Palmolive positions in Q3 2013 and 55 closed out, a net change of +7 holders.
- The largest Colgate-Palmolive buyer in Q3 2013 was OppenheimerFunds, an estimated $248M added.
- The largest Colgate-Palmolive seller in Q3 2013 was T. Rowe Price Associates, an estimated $224M sold.
Based on aggregated 13F filings for Q3 2013.